FDA Approves First New Drug in 20 Years for Sickle Cell | NBC Bay Area
National & International News
The day’s top national and international news

FDA Approves First New Drug in 20 Years for Sickle Cell

In a study, the new drug, Endari, cut the number of pain crises and dangerous chest complications, and reduced hospitalizations and the need for transfusions

    processing...

    NEWSLETTERS

    FDA Approves First New Drug in 20 Years for Sickle Cell
    ASSOCIATED PRESS
    In this March 7, 2007 file photo, a patient is given an injection for pain relief by a nurse at the Sickle Cell Center in Truman Medical Center, Wednesday, March 7, 2007 in Kansas City, Mo. Pain management is vital in the care of patients suffering from Sickle Cell disease.

    The U.S. Food and Drug Administration has approved the first drug in nearly 20 years for sickle cell, an inherited disease in which abnormally shaped red blood cells can't properly carry oxygen throughout the body, which can cause severe pain and organ damage.

    About 100,000 people in the U.S., mostly blacks, have the disorder and about 275,000 babies are born with it each year worldwide.

    In a study, the new drug, Endari, cut the number of pain crises and dangerous chest complications, and reduced hospitalizations and the need for transfusions.

    It is made by a California company, Emmaus Medical Inc., and approved for adults and children 5 and older.

    Rules Changing for Transgender Kids Hormone Therapies

    [NATL] Rules Changing for Transgender Kids Hormone Therapies

    In a series of tweets on July 26, President Donald Trump announced plans to ban transgender people from serving in the military "in any capacity." Trump cited "medical costs and disruption" as the reasons. His announcement comes just before the release of new, international medical guidelines that are expected to allow transgender children to alter their bodies at younger ages.

    (Published Wednesday, July 26, 2017)